The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Mechanisms of Statin-mediated Inhibition of Small G-protein Function
Open accessAbstract
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been reported to reduce the risk of Alzheimer disease. We have shown previously that statins inhibit a beta-amyloid (Abeta)-mediated inflammatory response through mechanisms independent of cholesterol reduction. Specifically, statins exert anti-inflammatory actions through their ability to prevent the isoprenylation of members of the Rho family of small G-proteins, resulting in the functional inactivation of these G-proteins. We report that statin treatment of microglia results in perturbation of the cytoskeleton and morphological changes due to alteration in Rho family function. Statins also block Abeta-stimulated phagocytosis through inhibition of Rac action. Paradoxically, the statin-mediated inactivation of G-protein function was associated with increased GTP loading of Rac and RhoA, and this effect was observed in myeloid lineage cells and other cell types. Statin treatment disrupted the interaction of Rac with its negative regulator the Rho guanine nucleotide dissociation inhibitor (RhoGDI), an interaction that is dependent on protein isoprenylation. We propose that lack of negative regulation accounts for the increased GTP loading. Isoprenylation of Rac is also required for efficient interaction with the plasma membrane, and we report that statin treatment dramatically reduces the capacity of Rac to interact with membranes. These results suggest a mechanism by which statins inhibit the actions of Rho GTPases and attenuate Abeta-stimulated inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, statins act as inhibitors of some G-protein actions and Ras or Ras-like signaling, which affect several important bioprocesses [15] .”
From Statins as antifungal agents (2011) · cites this paper as [15]
In the citing paper
“Beyond to the harmful effects on membrane fluidity and the synthesis of important isoprenoids for cell signaling and vital processes (such as cell proliferation and differentiation), and protein prenylation [16] , statins induce apoptosis-like cell death in filamentous fungi [15,30,31] .”
From Statins as antifungal agents (2011) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,511
Rho GTPases and signaling networksPreprint
Aelst, L. V., & D’Souza‐Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 2,018
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
Flagged first, then by citations
Research works printed but not linked: 2
- Buxbaum, 2002, Front. Biosci., 7, a50
- Patel, 2005, J. Neuroinflammation
Cited by
Sorted by citations
Items 101–200 of 235
Repurposing of statins via inhalation to treat lung inflammatory conditions
Bradbury, P., Traini, D., Ammit, A. J., Young, P. M., & Ong, H. X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.005 · Cited by 38
Milenkovic, U., Ilg, M. M., Zuccato, C., Ramazani, Y., De Ridder, D., & Albersen, M. (2019) · BJU International · doi:10.1111/bju.14638 · Cited by 38
Galgóczy, L., Papp, T., Lukács, G., Leiter, Ã., Pócsi, I., & Vágvölgyi, C. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00661.x · Cited by 37
Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling
Binnington, B., Nguyen, L., Kamani, M., Hossain, D., Marks, D. L., Budani, M., & Lingwood, C. A. (2015) · Glycobiology · doi:10.1093/glycob/cwv084 · Cited by 37
Chen, X.-Y., Li, K., Light, A. R., & Fu, K. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.05.011 · Cited by 36
Effect of pravastatin and fosinopril on recurrent urinary tract infections
Pouwels, K. B., Visser, S. T., & Hak, E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks419 · Cited by 36
Statins in Neurological Disorders: Mechanisms and Therapeutic Value
Reiss, A. B., & Wirkowski, E. J. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.141 · Cited by 36
Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications
Butchart, J., & Holmes, C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 36
Statins: A New Approach to Combat Temozolomide Chemoresistance in Glioblastoma
Shojaei, S., Alizadeh, J., Thliveris, J. A., Koleini, N., Kardami, E., Hatch, G. M., Xu, F. Y., Hombach‐Klonisch, S., Klonisch, T. C., & Ghavami, S. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000874 · Cited by 35
Nyilasi, I., Kocsubé, S., Pesti, M., Lukács, G., Papp, T., & Vágvölgyi, C. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.013946-0 · Cited by 35
Lee, C.-L., Lin, P.-Y., Hsu, Y.-W., & Pan, T. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.08.002 · Cited by 34
Geranylgeranylation but Not GTP Loading Determines Rho Migratory Function in T Cells
Waiczies, S., Bendix, I., Prozorovski, T., Ratner, M., Nazarenko, I. A., Pfueller, C. F., Brandt, A. U., Herz, J., Brocke, S., Ullrich, O., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6024 · Cited by 34
Miriyala, S., Subramanian, T., Panchatcharam, M., Ren, H., McDermott, M. I., Sunkara, M., Drennan, T., Smyth, S. S., Spielmann, H. P., & Morris, A. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083931 · Cited by 34
Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease
Savage, M. J., & Gingrich, D. E. (2009) · Drug Development Research · doi:10.1002/ddr.20287 · Cited by 33
Kraft, R., Kahn, A., Medina‐Franco, J. L., Orlowski, M. L., Baynes, C., López-Vallejo, F., Barnard, K., Maggiora, G. M., & Restifo, L. L. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008243 · Cited by 33
Attenuation of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats by Rosuvastatin
Li, X., Guan, R.-J., & Li, J. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31825cce63 · Cited by 32
Hooff, G. P., Volmer, D. A., Wood, W. G., Müller, W. E., & Eckert, G. P. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2306-3 · Cited by 32
Simvastatin Attenuates Neuropathic Pain by Inhibiting the RhoA/LIMK/Cofilin Pathway
Qiu, Y., Chen, W. Y., Wang, Z., Liu, F., Wei, M., Ma, C., & Huang, Y. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1958-1 · Cited by 31
Statins in Endothelial Signaling and Activation
Jacobson, J. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2284 · Cited by 32
Statins inhibit T-acute lymphoblastic leukemia cell adhesion and migration through Rap1b
Infante, E., Heasman, S. J., & Ridley, A. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0810441 · Cited by 31
The impact of statin use on atrial fibrillation
Sánchez-Quiñones, J., Marín, F. R., Roldán, V., & Lip, G. Y. H. (2008) · QJM · doi:10.1093/qjmed/hcn101 · Cited by 31
Mansouri, M. T., Khodayar, M. J., Tabatabaee, A., Ghorbanzadeh, B., & Naghizadeh, B. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.08.002 · Cited by 30
The Cytostatic Effects of Lovastatin on ACC-MESO-1 Cells
Asakura, K., Izumi, Y., Yamamoto, M., Yamauchi, Y., Kawai, K., Serizawa, A., Mizushima, T., Ohmura, M., Kawamura, M., Wakui, M., et al. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.06.037 · Cited by 29
Budman, D. R., Tai, J. Y., & Calabro, A. R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9395-5 · Cited by 30
Benati, D., Ferro, M., Savino, M. T., Ulivieri, C., Schiavo, E., Nuccitelli, A., Pasini, F. L., & Baldari, C. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409273 · Cited by 29
Jaikumkao, K., Pongchaidecha, A., Chattipakorn, N., Chatsudthipong, V., Promsan, S., Arjinajarn, P., & Lungkaphin, A. (2016) · Experimental Physiology · doi:10.1113/ep085571 · Cited by 28
Escudero, P., Marañón, A., Collado, A., Navarro, H. G., Hermenegildo, C., Peiró, C., Piqueras, L., & Sanz, M. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5969 · Cited by 28
Hoffmann, A., Hofmann, F., Just, I., Lehnardt, S., Hanisch, U., Brück, W., Kettenmann, H., Ahnert‐Hilger, G., & Höltje, M. (2008) · Glia · doi:10.1002/glia.20687 · Cited by 28
Red mold fermented products and Alzheimer's disease: a review
Lee, C.-L., & Pan, T. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3413-1 · Cited by 28
Ogura, T., Tanaka, Y., Nakata, T., 並河知子, Kataoka, H., & OHTSUBO, Y. (2007) · The Journal of Toxicological Sciences · doi:10.2131/jts.32.57 · Cited by 24
Galgóczy, L., Lukács, G., Nyilasi, I., Papp, T., & Vágvölgyi, C. (2010) · Acta Biologica Hungarica · doi:10.1556/abiol.61.2010.3.11 · Cited by 23
Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
Linnenberger, R., Hoppstädter, J., Wrublewsky, S., Ampofo, E., & Kiemer, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212480 · Cited by 23
Sirangelo, I., Iannuzzi, C., Vilasi, S., Irace, G., Giuberti, G., Misso, G., D’Alessandro, A., Abbruzzese, A., & Caraglia, M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21871 · Cited by 22
Antileishmanial effect of mevastatin is due to interference with sterol metabolism
Dinesh, N., Soumya, N., & Singh, S. (2015) · Parasitology Research · doi:10.1007/s00436-015-4618-5 · Cited by 22
Statins Impair CD1d-Mediated Antigen Presentation through the Inhibition of Prenylation
Khan, M. A., Gallo, R. M., Renukaradhya, G. J., Du, W., Gervay‐Hague, J., & Brutkiewicz, R. R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804311 · Cited by 22
Erikstrup, C., Ullum, H., & Pedersen, B. K. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03042.x · Cited by 22
Hagiwara, N., Watanabe, M., Iizuka-Ohashi, M., Yokota, I., Toriyama, S., Sukeno, M., Tomosugi, M., Sowa, Y., Hongo, F., Mikami, K., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.025 · Cited by 22
Galgóczy, L. (2011) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v1.i1.4 · Cited by 21
Simvastatin alters fibroblastic cell responses involved in tissue repair
Cáceres, M., Romero, A., Copaja, M., Dı́az-Araya, G., Martı́nez, J., & Smith, P. C. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01360.x · Cited by 21
Cholesterol load of microglia: Contribution of membrane architecture changes to neurotoxic power?
Račková, L. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.06.015 · Cited by 22
Selim, A. M., Khalaf, M. M., Gad, A. M., & El‐Raouf, O. M. A. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21957 · Cited by 21
Determinants of urinary tract infection in hospitalized patients with acute ischemic stroke
Jitpratoom, P., & Boonyasiri, A. (2023) · BMC Neurology · doi:10.1186/s12883-023-03296-2 · Cited by 20
Huang, B., Li, F., Wu, C. H., & Wang, D. L. (2012) · Proteome Science · doi:10.1186/1477-5956-10-43 · Cited by 20
Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies
Antel, J. P., & Miron, V. E. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.03.021 · Cited by 20
Fahmy, U. A., & Aljaeid, B. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1236788 · Cited by 19
Shiota, M., Kusakabe, H., Hikita, Y., Nakao, T., Izumi, Y., & Iwao, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r01fm · Cited by 19
Assessment of the in vitro and in vivo activity of atorvastatin against Candida albicans.
Ajdidi, A., Sheehan, G., Abu Elteen, K., & Kavanagh, K. (2019) · Journal of medical microbiology · doi:10.1099/jmm.0.001065 · Cited by 18
Neurobiological Opportunities in Diabetic Polyneuropathy
Poitras, T. M., Munchrath, E., & Zochodne, D. W. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01138-y · Cited by 19
Rajesh, V., Mridhulmohan, M., Jayaseelan, S., Sivakumar, P., & Ganesan, V. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2554-3 · Cited by 18
Famer, D., Wahlund, L., & Crisby, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.035 · Cited by 18
Joerchel, S., Raap, M., Bigl, M., Eschrich, K., & Schliebs, R. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.01.004 · Cited by 19
Burns, E. M., Smelser, L. K., Then, J. E., Stankiewicz, T. E., Kushdilian, M. V., McDowell, S. A., & Bruns, H. A. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314020014 · Cited by 17
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity
Almramhi, M. M., Finan, C., Storm, C. S., Schmidt, A. F., Kia, D. A., Coneys, R., Chopade, S., Hingorani, A. D., & Wood, N. W. (2023) · Neurology · doi:10.1212/wnl.0000000000207777 · Cited by 16
Statins Perturb Gβγ Signaling and Cell Behavior in a Gγ Subtype Dependent Manner
Tennakoon, M., Kankanamge, D., Senarath, K., Fasih, Z., & Karunarathne, A. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.114710 · Cited by 17
Sarkar, P., Kumar, G. A., Shrivastava, S. K., & Chattopadhyay, A. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100206 · Cited by 16
García‐Álvarez, I., Fernández‐Mayoralas, A., Moreno-Lillo, S., Sánchez-Sierra, M., Nieto‐Sampedro, M., & Doncel‐Pérez, E. (2015) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-150572 · Cited by 16
Biselli-Chicote, P. M., Lotierzo, A. T., Biselli, J. M., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.01.025 · Cited by 16
Lu, Y., Liu, X., Zhou, J., Huang, A., Zhou, J., & He, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.519744 · Cited by 16
Palu, '. K., Brown, A., Deng, S., Kaluhiokalani, N., & Brett., J. W. (2012) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2012.2905 · Cited by 15
Zanin, V., Marcuzzi, A., Kleiner, G., Piscianz, E., Monasta, L., Zacchigna, S., Crovella, S., & Zauli, G. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9506-8 · Cited by 15
In vitro interaction between suramin and fluvastatin against clinically important Zygomycetes
Galgóczy, L., Papp, T., & Vágvölgyi, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01634.x · Cited by 14
The Mevalonate Pathway in Alzheimer’s Disease — Cholesterol and Non-Sterol Isoprenoids
Mohamed, A., Smith, K. T., & Chaves, E. (2015) · InTech eBooks · doi:10.5772/59904 · Cited by 17
Waiczies, S., Bendix, I., & Zipp, F. (2008) · Science Signaling · doi:10.1126/stke.112pt3 · Cited by 14
Pouwels, K. B., Widyakusuma, N. N., Bos, J., & Hak, E. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4052 · Cited by 14
Zhang, Y., Li, D., Wu, S., Chen, P., & Zhao, S. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131801 · Cited by 13
Rosendo, A. B., Lima, L. O., Dal‐Pizzol, F., & Almeida, S. (2010) · Inflammation · doi:10.1007/s10753-009-9178-3 · Cited by 13
Arcaro, A., Pirozzi, F., Angelini, A., Chimenti, C., Crotti, L., Giordano, C., Mancardi, D., Torella, D., & Tocchetti, C. G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6353469 · Cited by 12
Vital, K. D., Cardoso, B. G., Lima, I. P., Campos, A. B. D. C., Teixeira, B. F., Pires, L. O., Dias, B. C., Candido, P. D. A., Cardoso, V. N., & Fernandes, S. O. A. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12859 · Cited by 12
Novel effects of statins in enhancing efficacy of chemotherapy in vitro in nasopharyngeal carcinoma
Wang, W., Le, W., Cho, D., Hwang, P. H., & Upadhyay, D. (2011) · International Forum of Allergy & Rhinology · doi:10.1002/alr.20039 · Cited by 12
Roelofs, A. J., Ebetino, F. H., Reszka, A. A., Russell, R. G. G., & Rogers, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00095-1 · Cited by 12
Short-term treatment with Atorvastatin selectively decreases Lymphocyte count
Almukhtar, H. M., Faisal, I., & Merkhan, M. M. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00114 · Cited by 11
Pharmacologic Therapies on the Horizon for Acute Lung Injury/Acute Respiratory Distress Syndrome
Jacobson, J. R. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181c04681 · Cited by 11
Padró, T., Lugano, R., García-Arguinzonis, M., & Badimón, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038935 · Cited by 11
The Emerging Role of Statins in Glaucoma Pathological Mechanisms and Therapeutics
Pokrovskaya, O., Wallace, D., & O'Brien, C. J. (2014) · Open Journal of Ophthalmology · doi:10.4236/ojoph.2014.44021 · Cited by 11
Inactivation of Rho GTPases by Statins Attenuates Anthrax Lethal Toxin Activity
deCathelineau, A. M., & Bokoch, G. (2008) · Infection and Immunity · doi:10.1128/iai.01005-08 · Cited by 11
Hirano, M., & Hirano, K. (2022) · The Journal of Physiological Sciences · doi:10.1186/s12576-022-00857-x · Cited by 10
Holvoet, P., & Sinnaeve, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.024 · Cited by 10
Butterfield, D. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.014 · Cited by 9
Chen, Y., Xu, Y., Wang, J., Prisinzano, P. M., Yuan, Y., Lu, F., Zheng, M., Mao, W., & Wan, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.853063 · Cited by 10
Kim, Y. C., Song, S. B., Lee, S., Park, S. M., & Kim, Y. S. (2014) · Immune Network · doi:10.4110/in.2014.14.2.116 · Cited by 9
RhoA and Rac1 Changes in the Atherosclerotic Lesions of WHHLMI Rabbits
Ohkawara, H., Ishibashi, T., Shiomi, M., Sugimoto, K., Uekita, H., Kamioka, M., Takuwa, Y., Teramoto, T., Maruyama, Y., & Takeishi, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2394 · Cited by 9
Messina, S. (2018) · Small GTPases · doi:10.1080/21541248.2018.1502591 · Cited by 8
Role of vitamin D in the pathogenesis of atheromatosis
Rimondi, E., Marcuzzi, A., Casciano, F., Tornese, G., Pellati, A., Toffoli, B., Secchiero, P., & Melloni, E. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.08.031 · Cited by 7
Kowluru, A., & Gleason, N. F. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114886 · Cited by 7
Efectos no hipolipemiantes de las estatinas
Ramos-Esquivel, A., & Céspedes, C. L. (2009) · Acta Médica Costarricense · doi:10.51481/amc.v49i4.330 · Cited by 12
Hussein, H. M., Al-Khoury, D. K., Abdelnoor, A. M., & Rahal, E. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-48282-2 · Cited by 6
Asari, K., Sun, W. T., Kok, Z. H., Lam, Y. H., Ng, B. L., Saunders, V. A., White, D. L., Chuah, C. T. H., & Xiang, W. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001028 · Cited by 6
Chen, J., Song, M., Qian, D., Liu, L., Yang, K., Shou, Y., Zhao, H., & ZHANG, L. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.20.03910-5 · Cited by 6
Alizadeh, J., Shojaei, S., Rosa, S. C. D. S., Moghadam, A. R., Zeki, A. A., Hashemi, M. M., Łoś, M., Gordon, J. W., & Ghavami, S. (2018) · Journal of Visualized Experiments · doi:10.3791/57646 · Cited by 5
El-Fattah, N. A., Eid, A., Zaky, H. S., & Ibrahim, H. (2021) · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2021.206679 · Cited by 4
Evidence for a proximal site of action of atrial natriuretic peptide in man.
Semmekrot, B. A., Theelen, B., & Monnens, L. (1990) · PubMed · Cited by 4
Statin Gastroprotective Mechanisms Independent of Gastric Acid Suppression
Abdullah, D., & Almukhtar, H. M. (2023) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2023.142864.01056 · Cited by 3
Therapeutics of Alzheimer’s Disease
Herrera-Rivero, M., & Emiliano, G. (2011) · InTech eBooks · doi:10.5772/27990 · Cited by 3
Potential Therapeutic Strategies for Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_9 · Cited by 2
Disruption of Fungi Cell Membranes by Polyenes, Azoles, Allylamines, Amino Acids and Peptides
Aderiye, B. I. (2015) · International Scientific Research Journal · doi:10.18483/irjsci.13 · Cited by 2
Farmacogenética e efeito antiinflamatório dos inibidores da HMG-CoA redutase
Rosendo, A. B., Dal‐Pizzol, F., Fiegenbaum, M., & Almeida, S. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400004 · Cited by 2
Ye, L., Naskar, R., & Hwang, I. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116370 · Cited by 1
Tanaka, J., Kuwajima, H., Yuki, R., & Nakayama, Y. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111172 · Cited by 1
Protective Role of Rho Guanosine Diphosphate Dissociation Inhibitor, Ly-GDI, in Pulmonary Alveolitis
Yan, C., Wang, X., Liu, Y., Abdulnour, R.-E. E., Wu, M., & Gao, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140804 · Cited by 1
Metadata
- Authors
- Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A., & Landreth, G.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Landreth, Gary
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 280
- Issue
- 40
- Pages
- 34202-34209
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2015034968
- Cited by
- 235
- References
- 64
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 1 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 10 · 2015: 15 · 2014: 9 · 2013: 14 · 2012: 10
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-20202, R01AG020202, R01AG016740, AG-16740)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- statins, Rho GTPases, Rac, RhoA, isoprenylation, amyloid-beta, Alzheimer's disease, microglia, inflammation, RhoGDI, GTP loading, membrane association, cytoskeleton, phagocytosis
- MeSH terms
- Alzheimer Disease, Animals, Cell Line, Cytoskeleton, Guanosine Triphosphate, Humans, Inflammation, Monocytes, Phagocytosis, Protein Prenylation, Microglia, Hydroxymethylglutaryl-CoA Reductase Inhibitors, rho GTP-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
